Manabu Ono

494 total citations
18 papers, 321 citations indexed

About

Manabu Ono is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology and Allergy. According to data from OpenAlex, Manabu Ono has authored 18 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 3 papers in Physiology and 3 papers in Immunology and Allergy. Recurrent topics in Manabu Ono's work include Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Neonatal Respiratory Health Research (4 papers). Manabu Ono is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Neonatal Respiratory Health Research (4 papers). Manabu Ono collaborates with scholars based in Japan, United States and Canada. Manabu Ono's co-authors include Masakazu Ichinose, Yoshinori Okada, Shinya Ohkouchi, Hiromasa Ogawa, Toshiya Irokawa, Hájíme Kurosawa, Makoto Kobayashi, Satoru Yanagisawa, Seiichi Kobayashi and Masaru Yanai and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Molecular Therapy.

In The Last Decade

Manabu Ono

16 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manabu Ono Japan 9 147 85 58 54 53 18 321
Agnes Banfalvi United States 6 302 2.1× 161 1.9× 28 0.5× 36 0.7× 41 0.8× 7 482
Subia Tasneem Canada 13 54 0.4× 82 1.0× 40 0.7× 17 0.3× 18 0.3× 26 341
Kanae Ono Japan 12 106 0.7× 146 1.7× 23 0.4× 28 0.5× 59 1.1× 19 360
Emiko Maeda Japan 8 77 0.5× 69 0.8× 64 1.1× 12 0.2× 45 0.8× 13 432
F. Chellini Italy 10 61 0.4× 117 1.4× 22 0.4× 15 0.3× 59 1.1× 12 370
Sheila Santín Spain 10 71 0.5× 163 1.9× 75 1.3× 37 0.7× 11 0.2× 11 452
C. Merlin France 10 74 0.5× 71 0.8× 12 0.2× 35 0.6× 53 1.0× 31 332
Mirjam P. Roffel Netherlands 8 296 2.0× 130 1.5× 77 1.3× 131 2.4× 13 0.2× 11 538
Hang‐bo Zhou China 10 87 0.6× 159 1.9× 26 0.4× 46 0.9× 111 2.1× 43 347
Brigitte Spath Germany 8 38 0.3× 134 1.6× 83 1.4× 11 0.2× 39 0.7× 14 401

Countries citing papers authored by Manabu Ono

Since Specialization
Citations

This map shows the geographic impact of Manabu Ono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manabu Ono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manabu Ono more than expected).

Fields of papers citing papers by Manabu Ono

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manabu Ono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manabu Ono. The network helps show where Manabu Ono may publish in the future.

Co-authorship network of co-authors of Manabu Ono

This figure shows the co-authorship network connecting the top 25 collaborators of Manabu Ono. A scholar is included among the top collaborators of Manabu Ono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manabu Ono. Manabu Ono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kobayashi, Seiichi, et al.. (2025). Bronchiectasis in Japanese patients with chronic obstructive pulmonary disease: A prospective cohort study. Respiratory Investigation. 63(5). 942–948.
2.
Kobayashi, Seiichi, et al.. (2023). Physical activity and outcomes in Japanese patients with chronic obstructive pulmonary disease: From the Ishinomaki COPD Network registry. Respiratory Investigation. 62(1). 107–112. 4 indexed citations
3.
Ono, Manabu, et al.. (2022). A case of metastatic endobronchial tumor from uterine leiomyosarcoma. Respiratory Medicine Case Reports. 40. 101747–101747.
4.
Ohkouchi, Shinya, Masahiko Kanehira, Daisuke Saigusa, et al.. (2022). Metabolic and Epigenetic Regulation of SMAD7 by STC1 Ameliorates Lung Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 67(3). 320–333. 7 indexed citations
5.
Kobayashi, Seiichi, et al.. (2021). Exhaled nitric oxide: A biomarker for chronic obstructive pulmonary disease. Respiratory Investigation. 59(3). 364–366. 10 indexed citations
6.
Futamura, Masaki, Hiroya Hashimoto, Manabu Ono, et al.. (2020). Association between sites and severity of eczema and the onset of cow’s milk and egg allergy in children. PLoS ONE. 15(10). e0240980–e0240980. 5 indexed citations
7.
Kobayashi, Seiichi, Masakazu Hanagama, Manabu Ono, et al.. (2020). <p>Clinical Characteristics and Outcomes of Patients with Asthma–COPD Overlap in Japanese Patients with COPD</p>. International Journal of COPD. Volume 15. 2923–2929. 5 indexed citations
8.
Ono, Manabu, Seiichi Kobayashi, Masakazu Hanagama, et al.. (2020). Clinical characteristics of Japanese patients with chronic obstructive pulmonary disease (COPD) with comorbid interstitial lung abnormalities: A cross-sectional study. PLoS ONE. 15(11). e0239764–e0239764. 8 indexed citations
9.
Kato, Taisuke, et al.. (2019). [ORAL AND SYSTEMIC SYMPTOMS IN CHILDREN WITH FRUIT ALLERGY].. PubMed. 67(2). 129–138. 2 indexed citations
10.
Ohkouchi, Shinya, Naoki Tode, Makoto Kobayashi, et al.. (2018). Peripheral alveolar nitric oxide concentration reflects alveolar inflammation in autoimmune pulmonary alveolar proteinosis. ERJ Open Research. 4(1). 71–2017. 3 indexed citations
11.
Kobayashi, Seiichi, Masakazu Hanagama, Hikari Sato, et al.. (2018). Clinical characteristics and outcomes in Japanese patients with COPD according to the 2017 GOLD classification: the Ishinomaki COPD Network Registry. International Journal of COPD. Volume 13. 3947–3955. 26 indexed citations
12.
Yanagisawa, Satoru, Tatsuro Fukuhara, Eisaku Miyauchi, et al.. (2018). Relapsed Myasthenia Gravis after Nivolumab Treatment. Internal Medicine. 57(13). 1893–1897. 26 indexed citations
13.
Ono, Manabu, Ryoko Saito, Junya Tominaga, et al.. (2017). Pathological features of explant lungs with fibrosis in autoimmune pulmonary alveolar proteinosis. Respirology Case Reports. 5(5). e00255–e00255. 10 indexed citations
14.
Ito, Komei, Manabu Ono, Naoyuki Kando, et al.. (2017). Surveillance of the use of adrenaline auto-injectors in Japanese children. Allergology International. 67(2). 195–200. 11 indexed citations
15.
Ohkouchi, Shinya, Manabu Ono, Makoto Kobayashi, et al.. (2015). Myriad Functions of Stanniocalcin-1 (STC1) Cover Multiple Therapeutic Targets in the Complicated Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF). SHILAP Revista de lepidopterología. 9s1(Suppl 1). CCRPM.S23285–CCRPM.S23285. 23 indexed citations
16.
Ono, Manabu, Shinya Ohkouchi, Masahiko Kanehira, et al.. (2014). Mesenchymal Stem Cells Correct Inappropriate Epithelial–mesenchyme Relation in Pulmonary Fibrosis Using Stanniocalcin-1. Molecular Therapy. 23(3). 549–560. 93 indexed citations
17.
Yanagisawa, Satoru, et al.. (2013). Successful Crizotinib Retreatment after Crizotinib-Induced Interstitial Lung Disease. Journal of Thoracic Oncology. 8(8). e73–e74. 27 indexed citations
18.
Miyashita, Hiroki, Tatsuaki Watanabe, Hideki Hayashi, et al.. (2012). Angiogenesis Inhibitor Vasohibin-1 Enhances Stress Resistance of Endothelial Cells via Induction of SOD2 and SIRT1. PLoS ONE. 7(10). e46459–e46459. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Agnes Banfalvi Breakdown of academic impact, for papers by Subia Tasneem Breakdown of academic impact, for papers by Kanae Ono Breakdown of academic impact, for papers by Emiko Maeda Breakdown of academic impact, for papers by F. Chellini Breakdown of academic impact, for papers by Sheila Santín Breakdown of academic impact, for papers by C. Merlin Breakdown of academic impact, for papers by Mirjam P. Roffel Breakdown of academic impact, for papers by Hang‐bo Zhou Breakdown of academic impact, for papers by Brigitte Spath
Rankless by CCL
2026